简介：

简介：AIM:Todeterminetheclinicalfeatures,diagnosisandtreatmentoftheprimarySjogrensyndrome(SS)relatedopticneuritis.METHODS:Theclinicaldataof8patients(12eyes)withprimarySSrelatedopticneuritiswereanalyzedretrospectively.RESULTS:Eightof128consecutivepatientswithopticneuritisresultedfromvariedcausesfulfilledthediagnosticcriteriafortheprimarySS.Theypresentedinitiallywiththesignsandsymptomsofnon-specificopticneuritis,and5patientspresentingwithoutdrynessshowedachronicinflammationofsubmandibularglandorparotidgland,andlymphocyteinfiltrationwasdemonstratedbylabialglandbiopsyin2patients.Therewereserumpositivetitersforanti-SjogrensyndromeA(SSA)in7patientsandanti-SjogrensyndromeB(SSB)in8patients.Anti-aquaporin-4(AQP4)antibodywasnegativeinallthe8patients.Bothglucocorticoidsandimmunosuppressiveagentwereadministered,andvisualacuityelevatedin8eyes(66.7%),3patients(37.5%)recurredinthefollow-up.CONCLUSION:PrimarySSrelatedopticneuritisislesscommonandeasilymisdiagnosed.Theconventionaltherapiesforopticneuritiscouldnotcontroltherecurrence.

简介：Leber'scongenitalamaurosis(LCA)andrecentgenetherapyadvancementfortreatinginheritedretinopathieswereextensiveliteraturereviewedusingMEDLINE,PubMedandEMBASE.Adeno-associatedviralvectorswerethemostutilisedvectorsforoculargenetherapy.Conephotoreceptorcellsmightuseanalternatepathwaywhichwasnotreliantoftheretinalpigmentepithelium(RPE)derivedretinoidisomerohydrolase(RPE65)toaccessthe11-cisretinaldehydechromophore.Researcheffortsdedicatedontheprogressionofagene-basedtherapyforthetreatmentofLCA2.Suchgenetherapyapproacheswereextremelysuccessfulincanine,porcineandrodentLCA2models.TherecombinantAAV2.hRPE65v2adenoassociatedvectorcontainedtheRPE65cDNAandwasreplicationdeficient.ItsinvitroinjectionintargetcellsinducedRPE65proteinproduction.Thegenetherapytrialsthatweresofarconductedforinheritedretinopathieshavegeneratedpromisingresults.PhaseIclinicaltrialstocureLCAandchoroideremiademonstratedthatadeno-associatedviralvectorscontainingRPEgenesandphotoreceptorsrespectively,couldbesuccessfullyadministeredtoinheritedretinopathypatients.AphaseIIItrialispresentlyongoingandifsuccessful,itwillleadthewaytoadditionalgenetherapyattemptstocuremonogenic,inheritedretinopathies.

简介：

简介：~~

简介：Aim:ToverifywhetherpartialintraoperativeTenon'scapsuleresection(PTCR)withadjunctiveMitomycinCiseffectiveindevelopingthin,avascularblebsineyesundergoingAhmedglaucomavalveinsertionandtoassesstheefficacyandsafetyofthisprocedure.Methods:ThisstudywasconductedinfourLatinAmericacountries(Argentina,Brazil,ColombiaandPeru).AhmedglaucomavalveimplantinsertionwithPTCR(groupA)andwithoutPCTR(groupB)wasperformedinneovascular

简介：白内障是最常见的致盲眼病之一。谷胱甘肽S转移酶（glutathioneS-transferases,GSTs）是典型的多功能酶,主要催化各种化学剂与谷胱甘肽结合。近些年的研究表明,GSTs有抗过氧化引起的白内障作用。GSTs表达水平的高低在白内障形成中有着重要的作用。我们将近年来GSTs与年龄相关性白内障的研究情况做一综述。

简介：AIMTo在Descemet的家根据厚度评估视觉尖酸和endothelial房间密度剥去自动化endothelialkeratoplasty(DSAEK)在外科以后的年。

简介：

简介：P75神经营养受体是最早发现的神经营养因子受体,既往认为其主要作为高亲和力受体的辅助受体间接发挥作用.近年来研究表明,P75神经营养受体在神经系统的发育中有诱导细胞凋亡作用.现阐述其在视网膜神经细胞生长,分化以及逆向运输神经营养因子等方面的作用.

简介：目的：观察tumstatin肽对体外培养的视网膜微血管内皮细胞迁移及P38MAPK蛋白表达的影响，初步探讨tumstatin肽抗视网膜内皮细胞迁移的机制。方法：采用细胞划痕实验测定tumstatin肽（T8肽）对血管内皮生长因子（VEGF）诱导下RF／6A细胞（恒河猴视网膜微血管内皮细胞）迁移的影响；Westernblotting检测T8肽对VEGF刺激后15，30，45，60min的RF／6A细胞P38MAPK蛋白水平的变化。结果：Tumstatin肽对RF／6A细胞迁移具有抑制作用，且可抑制VEGF对RF／6A细胞的促迁移作用，呈剂量依赖性。正常情况下，RF／6A细胞无P38MAPK蛋白的表达，但VEGF可诱导其表达P38MAPK蛋白，而tumstatin可抑制VEGF诱导的RF／6A细胞P38MAPK蛋白的表达（加入20mg／LT8肽30，45，60min时蛋白表达受到显著抑制，差异有显著性意义，P〈0．01）。结论：Tumstatin抑制视网膜微血管内皮细胞的迁移，其作用可能与P38MAPK通路有关。

简介：目的：探讨眼附属器B细胞非霍杰金淋巴瘤（B—cellnon-Hodgkinlymphoma，NHL）中Skp2，p27和PTEN的表达。方法：收集1995年到2011年青岛大学附属医院眼科石蜡包埋标本，用免疫组化法分别检测眼附属器B细胞NHL（n=30）标本中Skp2，p27和PTEN的表达，以眼部反应性淋巴组织增生（n=10）作为对照组。以患者的年龄、性别、发病部位，病理类型作为眼附属器B细胞NHL的的分类标准。结果：Skp2，p27和PTEN的表达与患者的年龄、性别、发病部位无关，而与病例类型有关。眼附属器B细胞NHLSkp2表达率与眼部反应性淋巴组织增生相比显著增高。p27，PTEN表达率与反应性淋巴组织增生相比显著降低。随眼附属器B细胞NHL病理分级的提高，Skp2的表达显著增高，p27和PTEN的表达显著降低。在黏膜相关淋巴组织结（mucosa—associatedlymphoidtissue，MALT）外边缘区B细胞淋巴瘤（diffuselargeB—celllymphoma，DLBCL）中，Skp2分别与p27，VFEN成负相关，p27和PTEN成正相关。结论：Skp2的表达升高，p27，PTEN蛋白的缺失以及可能与眼附属器B细胞NHL的发生有关；其中在MALT外边缘区DLBCL中，三种蛋白存在相关性。联合三种蛋白的检测眼附属器B细胞NHL的不同病理类型有重要意义。

简介：目的探讨6～10岁屈光不正儿童复方托品酰胺与阿托品电脑验光结果的差异性.方法对诊断为屈光不正的6～10岁患儿92人(184眼),先后分别给予复方托品酰胺验光和阿托品验光,并对其结果进行比较分析.结果(1)对既往持续戴镜的不伴内斜的远视眼,其结果符合率为97.22%;对未曾戴镜的远视眼,其结果符合率为10%.(2)对既往持续戴镜的近视眼,其结果符合率为100%;未戴镜的近视眼,其结果符合率为61.76%.结论对既往持续戴镜的不伴内斜的屈光不正儿童,复方托品酰胺验光可以代替阿托品验光.

简介：AIM:ToidentifythegeneticdefectinaChinesefamilywithbilateralprogressivechildhoodposteriorcataract.METHODS:Atwo-generationfamilywasrecruitedinthisstudy.Familyhistoryandclinicaldatawererecorded.AllreportedcandidategenesassociatedwithcongenitalposteriorcataractwerescreenedbydirectDNAsequencing.·RESULTS:Allaffectedindividualspresentedposterioropacitiesinthelens.Directsequencingofthecandidategenesshowedaheterozygousc.2668C>TvariationinEPHA2gene,whichresultedinthereplacementofargininebycysteineatcodon890(p.R890C).Thismutationwasfoundintwoaffectedindividuals,butwasnotobservedin200normalcontrols.·CONCLUSION:Wereportanovelmutation(p.R890C)intheEPHA2receptortyrosinekinasegene.ThefindingexpandsthemutationspectrumofEPHA2inassociationwithposteriorcataract.